ImmPACT Bio USA procures $18m
ImmPACT Bio USA Inc, an Israeli developer of novel cell therapies for treating cancer, has raised $18 million in funding.
ImmPACT Bio USA Inc, an Israeli developer of novel cell therapies for treating cancer, has raised $18 million in funding.
Copyright PEI Media
Not for publication, email or dissemination